Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (3): 250-255.doi: 10.11958/20231036
• Cell and Molecular Biology • Previous Articles Next Articles
XIANG Jinjie(), LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao△(
)
Received:
2023-07-12
Revised:
2023-09-02
Published:
2024-03-15
Online:
2024-03-13
Contact:
△E-mail: XIANG Jinjie, LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao. Molecular mechanisms of Ca2+-induced pyroptosis and adhesion changes of HK-2 cells in the formation of calcium-containing kidney stones[J]. Tianjin Medical Journal, 2024, 52(3): 250-255.
CLC Number:
基因名称 | 引物序列(5'→3') | 产物大小/bp |
---|---|---|
NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
下游:TCTGATTAGTGCTGAGTA | ||
Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
Tab.1 The sequences of primers for qRT-PCR
基因名称 | 引物序列(5'→3') | 产物大小/bp |
---|---|---|
NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
下游:TCTGATTAGTGCTGAGTA | ||
Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
组别 | 存活率 | 凋亡率 |
---|---|---|
对照组 | 100.00±2.03 | 2.15±0.83 |
0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
F | 820.800** | 19.970* |
Tab.2 Comparison of cell survival rate and apoptosis rate between seven groups
组别 | 存活率 | 凋亡率 |
---|---|---|
对照组 | 100.00±2.03 | 2.15±0.83 |
0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
F | 820.800** | 19.970* |
组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
---|---|---|---|---|---|---|---|---|---|
对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** |
Tab.3 Comparison of mRNA expression levels between three groups
组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
---|---|---|---|---|---|---|---|---|---|
对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** |
组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
---|---|---|---|---|---|
对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
Tab.4 Comparison of protein expression levels between three groups
组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
---|---|---|---|---|---|
对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
组别 | IL-1β | IL-18 | MCP-1 |
---|---|---|---|
对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
F | 231.700** | 224.800** | 102.500** |
Tab.5 Comparison of IL-1β, IL-18 and MCP-1 contents in the supernatant of cell culture between three groups
组别 | IL-1β | IL-18 | MCP-1 |
---|---|---|---|
对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
F | 231.700** | 224.800** | 102.500** |
[1] | FRANK D, VINCE J E. Pyroptosis versus necroptosis: similarities,differences,and crosstalk[J]. Cell Death Differ, 2019, 26(1):99-114. doi:10.1038/s41418-018-0212-6. |
[2] | JACKSON D N, THEISS A L. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer[J]. Gut Microbes, 2020, 11(3):285-304. doi:10.1080/19490976.2019.1592421. |
[3] | HUTTON H L, OOI J D, HOLDSWORTH S R, et al. The NLRP3 inflammasome in kidney disease and autoimmunity[J]. Nephrology (Carlton), 2016, 21(9):736-744. doi:10.1111/nep.12785. |
[4] | LI X, ZENG L, CAO C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy[J]. Exp Cell Res, 2017, 350(2):327-335. doi:10.1016/j.yexcr.2016.12.006. |
[5] | XU G, YUE F, HUANG H, et al. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis[J]. Aging(Albany NY), 2016, 8(5):977-985. doi:10.18632/aging.100957. |
[6] | HOU J, ZHAO R, XIA W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis[J]. Nat Cell Biol, 2020, 22(10):1264-1275. doi:10.1038/s41556-020-0575-z. |
[7] | THONGPRAYOON C, KRAMBECK A E, RULE A D. Determining the true burden of kidney stone disease[J]. Nat Rev Nephrol, 2020, 16(12):736-746. doi:10.1038/s41581-020-0320-7. |
[8] | THONGBOONKERD V. Proteomics of crystal-cell interactions:a model for kidney stone research[J]. Cells, 2019, 8(9):1076. doi:10.3390/cells8091076. |
[9] | COE F L, WORCESTER E M, EVAN A P. Idiopathic hypercalciuria and formation of calcium renal stones[J]. Nat Rev Nephrol, 2016, 12(9):519-533. doi:10.1038/nrneph.2016.101. |
[10] | DAUDON M, HENNEQUIN C, BOUJELBEN G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers[J]. Kidney Int, 2005, 67(5):1934-1943. doi:10.1111/j.1523-1755.2005.00292.x. |
[11] | ANDERS H J, SUAREZ-ALVAREZ B, GRIGORESCU M, et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury[J]. Kidney Int, 2018, 93(3):656-669. doi:10.1016/j.kint.2017.09.022. |
[12] | KHAN S R, CANALES B K, DOMINGUEZ-GUTIERREZ P R. Randall's plaque and calcium oxalate stone formation:role for immunity and inflammation[J]. Nat Rev Nephrol, 2021, 17(6):417-433. doi:10.1038/s41581-020-00392-1. |
[13] | RIZVI S H M, PARVEEN A, AHMAD I, et al. Aluminum activates PERK-EIF2α signaling and inflammatory proteins in human neuroblastoma SH-SY5Y cells[J]. Biol Trace Elem Res, 2016, 172(1):108-119. doi:10.1007/s12011-015-0553-7. |
[14] | KHASKHALI M H, BYER K J, KHAN S R. The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury[J]. Urol Res, 2009, 37(1):1-6. doi:10.1007/s00240-008-0160-6. |
[15] | JOSHI S, WANG W, PECK A B, et al. Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys[J]. J Urol, 2015, 193(5):1684-1691. doi:10.1016/j.juro.2014.11.093. |
[16] | LIN Q, LI S, JIANG N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biol, 2019, 26:101254. doi:10.1016/j.redox.2019.101254. |
[17] | LIU Q, LIU Y, GUAN X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals[J]. Kidney Blood Press Res, 2019, 44(4):777-791. doi:10.1159/000501558. |
[18] | QI S, WANG Q, XIE B, et al. P38 MAPK signaling pathway mediates COM crystal-induced crystal adhesion change in rat renal tubular epithelial cells[J]. Urolithiasis, 2020, 48(1):9-18. doi:10.1007/s00240-019-01143-z. |
[19] | KHAN S R. Reactive oxygen species,inflammation and calcium oxalate nephrolithiasis[J]. Transl Androl Urol, 2014, 3(3):256-276. doi:10.3978/j.issn.2223-4683.2014.06.04. |
[20] | QIN B, WANG Q, LU Y, et al. Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by inhibiting NADPH oxidase and oxidative stress[J]. Oxid Med Cell Longev, 2018, 2018:1271864. doi:10.1155/2018/1271864. |
[21] | ASSELMAN M, VERHULST A, DE BROE M E, et al. Calcium oxalate crystal adherence to hyaluronan-,osteopontin-,and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys[J]. J Am Soc Nephrol, 2003, 14(12):3155-3166. doi:10.1097/01.asn.0000099380.18995.f7. |
[22] | WANG Z, LI M X, XU C Z, et al. Comprehensive study of altered proteomic landscape in proximal renal tubular epithelial cells in response to calcium oxalate monohydrate crystals[J]. BMC Urol, 2020, 20(1):136. doi:10.1186/s12894-020-00709-z. |
[1] | GAO Pan, XIE Bingxin, ZHOU Zandong, LIU Tong. Promoting effect of circulating FGF23 on atrial fibrosis in chronic kidney disease [J]. Tianjin Medical Journal, 2024, 52(9): 917-923. |
[2] | LI Yong, SU Yakun, ZHANG Hongbo, LI Yuan, LI Zhanhu, YAN Xiaoju. Clinical significance of serum asprosin level in patients with early renal damage of essential hypertension [J]. Tianjin Medical Journal, 2024, 52(6): 609-613. |
[3] | CHU Jiyan, TIAN Jing, FU Diyu, GUO Lin, SUN Rui, LI Ping. Expression and significance of AIM2 inflammasome in patients with acute gouty arthritis [J]. Tianjin Medical Journal, 2024, 52(5): 518-522. |
[4] | WANG Yue, QUAN Xingmiao, WANG Yu, SONG Chunxia, SHAO Yue, XU Liwei. Influence of Yiqi Shengqing recipe on neuron pyroptosis in ischemic stroke rats by regulating HIF-1α/NLRP3 signal pathway [J]. Tianjin Medical Journal, 2024, 52(4): 350-355. |
[5] | FAN Hui, MA Yu, LI Ximing. Research progress in the prevention of contrast-related acute kidney injury [J]. Tianjin Medical Journal, 2024, 52(3): 327-330. |
[6] | YI Na, XIAO Wen, TIAN Yuan, YUAN Lili. Mechanism of BMAL1 attenuating H2O2-induced cardiomyocyte injury [J]. Tianjin Medical Journal, 2024, 52(2): 119-123. |
[7] | GU Wei, ZHANG Huina, HOU Liping, YU Min, CHENG Lirong. Correlation between lipid correlation index and diabetic kidney disease [J]. Tianjin Medical Journal, 2024, 52(12): 1308-1312. |
[8] | LIU Guoqi, LI Chengcheng, LIU Shengju, ZHU Liying. Emodin regulates histone acetylation to promote pyroptosis and apoptosis of HpG2 hepatoma cells [J]. Tianjin Medical Journal, 2024, 52(1): 56-60. |
[9] | WANG Xiaohong, QIAN Jing, WANG Jiawei, QI Xiaoming, MENG Yun, WANG Ping, CHENG Ruizhi, ZHOU Guoxiong. The study on the mechanism of salidroside in the adjuvant treatment of patients with moderately severe acute pancreatitis [J]. Tianjin Medical Journal, 2023, 51(7): 762-765. |
[10] | SUN Liyan, LIU Zeru, SU Yongsheng, AI Hongliang. Effect of asperuloside on pyroptosis of lung tissue in septic rats by regulating NLRP3/Caspase-1/GSDMD signaling pathway [J]. Tianjin Medical Journal, 2023, 51(6): 607-612. |
[11] | WANG Tianchi, WANG Zhong, NIU Ningning, TANG Ying. The value of ultrasonography in the differential diagnosis of parenchymal lesions of transplanted kidney [J]. Tianjin Medical Journal, 2023, 51(6): 653-657. |
[12] | GENG Yongzhi, YANG Li, LI Guowei, ZHANG Jintao, CHENG Xiaolei, TAN Liduan. Study on the improvement effect and mechanism of nobiletin on rats with acute kidney injury [J]. Tianjin Medical Journal, 2023, 51(5): 498-503. |
[13] | LIU Zhufeng, WANG Wenhong, FAN Shuying, LIU Yan, LIU Tao, WANG Xin, WU Xia. Protective effect of Klotho protein on acute renal injury and fibrosis in rats with ischemia-reperfusion [J]. Tianjin Medical Journal, 2023, 51(4): 371-375. |
[14] | PAN Ting, LI Zuoxiao, WAN Li. Study on the effect and mechanism of paclitaxel on pyroptosis in mice with experimental autoimmune encephalomyelitis [J]. Tianjin Medical Journal, 2023, 51(3): 259-262. |
[15] | JIN Heng, LIU Qihui, SUN Keke, SONG Jie, LYU Qi, ZHANG Yan. Advances in complications and management of rhabdomyolysis [J]. Tianjin Medical Journal, 2023, 51(3): 329-332. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||